Q4 2015 13F Holders as of 31 Dec 2015
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Number of holders
-
28
-
Total 13F shares, excl. options
-
13,867,564
-
Shares change
-
+46,924
-
Total reported value, excl. options
-
$79,311,000
-
Value change
-
+$271,944
-
Number of buys
-
15
-
Number of sells
-
-7
-
Price
-
$5.72
Significant Holders of GLYCOMIMETICS INC - Common Stock, par value $0.001 per share (GLYC) as of Q4 2015
31 filings reported holding GLYC - GLYCOMIMETICS INC - Common Stock, par value $0.001 per share as of Q4 2015.
GLYCOMIMETICS INC - Common Stock, par value $0.001 per share (GLYC) has 28 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 13,867,564 shares
.
Largest 10 shareholders include NEA Management Company, LLC (8,584,118 shares), WELLINGTON MANAGEMENT GROUP LLP (2,625,363 shares), FRANKLIN RESOURCES INC (1,009,979 shares), Cormorant Asset Management, LLC (283,555 shares), Candriam Luxembourg S.C.A. (220,000 shares), VANGUARD GROUP INC (217,002 shares), WALL STREET ASSOCIATES (150,000 shares), FMR LLC (149,192 shares), BRIDGEWAY CAPITAL MANAGEMENT INC (109,764 shares), and DEUTSCHE BANK AG\ (91,572 shares).
This table shows the top 28 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.